Navigation Links
VISULAS YAG III Laser Capsulotomy Systems

ProductsVISULAS YAG III Laser Capsulotomy Systems
Company Carl Zeiss Meditec, Inc.
Item VISULAS YAG III Laser Capsulotomy Systems
Features 
  • Safe: The Super-Gaussian beam profile ensures that optical breakdown is achieved with very low pulse energies. The result: fewer side effects for the patient and less risk.
  • Precise: The 4-point aiming beam system facilitates the ability to focus with extreme precision and to detect any astigmatic distortion before firing the laser.
  • Ergonomic: The design guarantees unobstructed visual contact with the patient and free access to the eye. The control console contains a large illuminated display for menu-guided operation.
Description The VISULAS YAG III is the new disruption laser from Carl Zeiss Meditec designed in particular for applications in posterior capsulotomy (post-cataract therapy) and iridotomy. However, the YAG laser is also used for trabeculotomy, anterior capsulotomy and for IOL polishing. It's another milestone in the development of state-of-the-art, practice-oriented ophthalmic laser systems for photodisruption.
Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. VISULAS 532s
2. VISULAS 690s Photodynamic Therapy Laser System
3. VISULAS YAG III Combi Complete Laser Therapy System
4. Full Handle Laseredge Stab Blade Knife, 15 blade
5. Full Handle Laseredge Stab Blade Knife, 15 blade, 3 mm
6. Full Handle Laseredge Stab Blade Knife, 22.5 blade
7. Full Handle Laseredge Stab Blade Knife, 45 blade
8. Full Handle Laseredge Stab Blade Knife, 30 blade
9. Full Handle Laseredge Crescent Blade Knife, angled bevel up
10. Full Handle Laseredge Crescent Blade Knife, straight
11. Full Handle Laseredge Crescent Blade Knife, angled double bevel
Enzymatic assay for the quantitative in vitro determination of glycated protein (fructosamine) in human serum or plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Carbamazepine in human serum...
For the quantitative in vitro determination of Transferrin in human serum...
Medicine Products:
(Date:1/20/2017)... ... January 20, 2017 , ... ... enhance people’s everyday lives, recently attended the January ECRM Trade Show in Hilton ... is known for its large range of supplements that keep the body functioning ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the ... an educator interacting with countless women who had little knowledge of the female characters ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: ... published author, Sara Seymour, who lives in Lafayette, Indiana where she works in a ... iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book ...
(Date:1/19/2017)... (PRWEB) , ... January 20, 2017 , ... Today, the ... to participate in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who ... patients. APMs are an important part of the Administration’s effort to build a ...
(Date:1/19/2017)... , ... January 19, 2017 , ... This month, the ... that the name of their drug rehab center in Delray Beach, Florida has been ... that not only stars such as Philip Seymour Hoffman and Chris Farley are dying ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... 2017 According to a study conducted by ... to witness a CAGR of 6.5% during the forecast period 2016-2024. ... continue to be the leading market for cryotherapy globally during the ... Highlights ... ensuring affordable and adequate supply of gas in order to provide ...
Breaking Medicine Technology: